Literature DB >> 27188241

Early neurological deterioration after thrombolysis: Clinical and imaging predictors.

Claus Z Simonsen1, Marie L Schmitz1, Mette H Madsen2, Irene K Mikkelsen3, Ronil V Chandra4, Thabele Leslie-Mazwi5, Grethe Andersen1.   

Abstract

BACKGROUND: National Institutes of Health Stroke Scale is the most common scale used in stroke patients. An increase of four points or more within 24 h signifies early neurological deterioration. We aimed to establish how often early neurological deterioration occurs in a cohort selected by magnetic resonance imaging and which factors predicted early neurological deterioration.
METHODS: In this single-center study, we collected epidemiological, imaging and outcome data on 569 consecutive patients undergoing reperfusion therapy after magnetic resonance imaging selection.
RESULTS: Of these, 33 (5.8%) experienced early neurological deterioration. Seven were due to a symptomatic intracerebral hemorrhage, 23 were caused by extension of ischemia on follow-up imaging and three were due to progression on the basis of small vessel disease. Early neurological deterioration was predicted by a larger perfusion lesion, higher blood glucose and presence of large vessel disease. Penumbra occurred in 34% of patients but only 9% of patients with penumbra experienced early neurological deterioration, thus eroding the value of penumbra as an imaging marker. Early neurological deterioration was a poor prognostic sign. Odds ratio for disability or death was 14.9 (95% confidence interval: 6.5-34.0).
CONCLUSION: Early neurological deterioration is rare. It originates mainly from ischemic infarct growth rather than from hemorrhage. Concern should be highest in patients with elevated blood glucose, larger perfusion lesions and large vessel disease. Prior aspirin use increases risk of symptomatic intracerebral hemorrhage.
© 2016 World Stroke Organization.

Entities:  

Keywords:  Acute cerebral infarction; emergency treatment of stroke; magnetic resonance imaging; perfusion-weighted imaging; thrombolysis

Mesh:

Year:  2016        PMID: 27188241     DOI: 10.1177/1747493016650454

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  32 in total

1.  Revisiting 'progressive stroke': incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke.

Authors:  Pierre Seners; Jean-Claude Baron
Journal:  J Neurol       Date:  2017-04-28       Impact factor: 4.849

2.  Perfusion profile evaluated by severity-weighted multiple Tmax strata predicts early neurological deterioration in minor stroke with large vessel occlusion.

Authors:  Dong-Seok Gwak; WooChan Choi; Jung-A Kwon; Dong-Hyun Shim; Yong-Won Kim; Yang-Ha Hwang
Journal:  J Cereb Blood Flow Metab       Date:  2021-09-24       Impact factor: 6.960

3.  Progression in acute ischemic stroke: Is widespread atherosclerotic background a risk factor?

Authors:  Mehmet Murat Sümer; Akçay Övünç Özön
Journal:  Turk J Phys Med Rehabil       Date:  2017-08-11

4.  Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register.

Authors:  Michael V Mazya; Charith Cooray; Kennedy R Lees; Danilo Toni; Gary A Ford; Michal Bar; Senta Frol; Tiago Moreira; Lakshmanan Sekaran; Viktor Švigelj; Nils Wahlgren; Niaz Ahmed
Journal:  Eur Stroke J       Date:  2017-11-29

Review 5.  The Role of Natural Antioxidants in the Prevention of Dementia-Where Do We Stand and Future Perspectives.

Authors:  Anamaria Jurcau
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

Review 6.  Acute ischemic stroke patients with diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score ≤ 5 can benefit from endovascular treatment: a single-center experience and literature review.

Authors:  Kangping Song; Min Guan; Wenxian Li; Zhen Jing; Xiaomei Xie; Changzheng Shi; Jianye Liang; Hongyu Qiao; Li'an Huang
Journal:  Neuroradiology       Date:  2019-02-06       Impact factor: 2.804

7.  A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis.

Authors:  Rita Orbán-Kálmándi; István Szegedi; Ferenc Sarkady; István Fekete; Klára Fekete; Nikolett Vasas; Ervin Berényi; László Csiba; Zsuzsa Bagoly
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

8.  Early Neurological Deterioration after Recanalization Treatment in Patients with Acute Ischemic Stroke: A Retrospective Study.

Authors:  Ying-Bo Zhang; Ying-Ying Su; Yan-Bo He; Yi-Fei Liu; Gang Liu; Lin-Lin Fan
Journal:  Chin Med J (Engl)       Date:  2018-01-20       Impact factor: 2.628

Review 9.  The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke.

Authors:  Qiang Dong; Yi Dong; Liping Liu; Anding Xu; Yusheng Zhang; Huaguang Zheng; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2017-06-02

10.  External Validation of the WORSEN Score for Prediction the Deterioration of Acute Ischemic Stroke in a Chinese Population.

Authors:  Yicheng Xu; Yu Chen; Ruiwei Chen; Fei Zhao; Peifu Wang; Shengyuan Yu
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.